fatty liver disease and semaglutide Why are GLP-1 agonists being used to treat patients with nonalcoholic disease? Semaglutide can reduce severity of

doi: 10.1038/ijo.2011.158 24 RyanDAcostaA

Figure 1 provides multiple pharmacotherapy options based on A1C levels, fasting or postprandial glucose control, weight loss, and adverse effects

With the right guidance, you can select a solution that fits your health goals, budget, and lifestyle

& Cronin-Fenton, D

Tiered vital-sign capture is uncommon outside hospital intake YOUR APPROVAL EXPIRES IN 14:54 fake-urgency timer Clinical Safety Screens Performed Suicidal thoughts and/or prior attempt named directly Current or prior eating disorder named Pancreatitis personal history (current or past) Pregnancy / breastfeeding / postpartum 6 months End-stage kidney + liver disease separately named T1D, T2D-on-insulin, T2D-not-on-insulin distinguished Diabetic retinopathy + warfarin use Opiate use last 3 months including street drugs Bariatric / abdominal / pelvic surgery BP tiered to AHA staging + HR tiered HTN, sleep apnea, high cholesterol, acid reflux Food allergies 7-option separate from medication allergies Most cash-pay GLP-1 funnels either skip blood pressure entirely or ask a single threshold yes/no (Is your BP above 140/90?)